1. Comparative analysis of immunological changes following realgar and arsenic trioxide treatments in a murine model of myelodysplastic syndrome.
- Author
-
Tao Y, Xue T, Li X, Guo R, Wang Y, Xu H, Hu K, Dong X, Wang D, Ren J, Guan Y, and Lu J
- Subjects
- Animals, Mice, Sulfides pharmacology, Sulfides administration & dosage, Disulfides pharmacology, T-Lymphocytes drug effects, T-Lymphocytes immunology, Spleen drug effects, Spleen immunology, Arsenic Trioxide administration & dosage, Arsenic Trioxide pharmacology, Arsenicals pharmacology, Arsenicals administration & dosage, Disease Models, Animal, Myelodysplastic Syndromes drug therapy, Myelodysplastic Syndromes immunology
- Abstract
Background: Myelodysplastic syndrome (MDS) is a prevalent hematological neoplastic disorder in clinics and its immunopathogenesis has garnered growing interest. Oral and intravenous arsenic agents have long been used to treat hematological malignancies. The main component of oral arsenic is realgar (arsenic disulfide), while arsenic trioxide is the main component of intravenous arsenic., Methods: This study aimed to assess the effects of ATO and Realgar on the enhancement of peripheral blood, drug safety, and T cell immune status in the NUP98-HOXD13 (NHD13) mice model of MDS, specifically in the peripheral blood, spleen, and liver., Results: The study findings indicate that realgar and arsenic trioxide (ATO) can improve peripheral hemogram in mice, whereas realgar promotes higher peripheral blood cell production than ATO. Furthermore, the clinical administration method and dose did not cause significant toxicity or side effects and thus can be considered safe. Coexistence and interconversion of hyperimmune function and immunosuppression in mice were also observed in this study. In addition, there were interactions between immune cells in the peripheral blood, spleen, and liver to regulate the immune balance of the body and activate immunity via T-cell activation., Conclusion: In summary, oral and intravenous arsenic agents are beneficial in improving peripheral hemogram and immunity in mice.
- Published
- 2024
- Full Text
- View/download PDF